Copyright
©The Author(s) 2023.
World J Clin Oncol. Sep 24, 2023; 14(9): 335-342
Published online Sep 24, 2023. doi: 10.5306/wjco.v14.i9.335
Published online Sep 24, 2023. doi: 10.5306/wjco.v14.i9.335
Phase | Resistance-associated proteins associated with PXR | Resistance-associated proteins associated with breast cancer | Resistance associated proteins associated with TNBC | Resistance related proteins known to be regulated by PXR in TNBC | Possible regulatory targets of PXR in TNBC (unconfirmed) |
Phase Ⅰ | CYP3A4, CYP3A23 | CYP3A4, CYP3A5 | CYP3A4 | CYP3A4 | CYP2C8 |
Enzymes metabolism | CYP3A11, CYP2B6 | CYP2C8, CYP2C9 | CYP4A11 | ||
CYPs | CYP2C8, CYP2C9 | CYP2J2, CYP1A1 | CYP4A22 | ||
CYP2C19, CYP1A | CYP1B1, CYP17A1 | CYP2C8 | |||
CYP2B9, CYP2C55 | CYP2B6, CYP2D6 | CYP1B1 | |||
CYP2C19, CYP2S1 | |||||
CYP4V2, CYP26A1 | |||||
CYP4A11, CYP4A22 | |||||
Phase Ⅱ | GSTA1, GSTA2 | GSTM1, GSTP1 | GSTP1 | ||
Enzymes conjugation | GSTA3, GSTM1 | GSTA1, GSTA2 | |||
GSTs | GSTM2, GSTM3 | ||||
GSTM4 | |||||
UGTs | UGT1A1, UGT1A6 | UGT1A, UGT2B7 | UGT1A1 | UGT1A1 | |
UGT1A3, UGT1A4 | |||||
Phase Ⅲ | ABCB1, ABCB2 | ABCC1, ABCC3 | ABCC1 | ABCC1 | |
Ttansporters | ABCC1, ABCC2 | ABCB1, ABCG2 | ABCG2 | ABCG2 | |
ABCs | ABCC3, ABCC4 | ABCC11 | ABCC11 | ||
ABCC5, ABCG2 |
- Citation: Rao ZZ, Tang ZW, Wen J. Advances in drug resistance of triple negative breast cancer caused by pregnane X receptor. World J Clin Oncol 2023; 14(9): 335-342
- URL: https://www.wjgnet.com/2218-4333/full/v14/i9/335.htm
- DOI: https://dx.doi.org/10.5306/wjco.v14.i9.335